Disease Info Card

Malignant Neoplasm Of Prostate

Information about Malignant Neoplasm Of Prostate: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Malignant Neoplasm Of Prostate

Most recent studies have shown that Malignant Neoplasm Of Prostate shares some biological mechanisms with adenocarcinoma, benign-prostatic-hypertrophy, bone-neoplasms, carcinoma, cell-invasion, hyperplasia, lymphatic-metastasis, malignant-neoplasm-of-breast, malignant-neoplasms, malignant-paraganglionic-neoplasm, mammary-neoplasms, metastatic-malignant-neoplasm-to-the-bone, metastatic-prostate-cancer, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, pain, prostate-adenocarcinoma, prostatic-hyperplasia, prostatic-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Malignant Neoplasm Of Prostate, and have been seen in publications frequently: Aging, Angiogenesis, Bone Resorption, Cell Adhesion, Cell Cycle, Cell Cycle Arrest, Cell Death, Cell Growth, Cell Migration, Cell Proliferation, Dna Methylation, Excretion, Immune Response, Induction Of Apoptosis, Localization, Methylation, Pathogenesis, Secretion, Translation, Transport

Quite a number of genes have been found to play important roles in Malignant Neoplasm Of Prostate, such as ACTR1B, AKR1B1, AKT1, AR, AREG, BTG2, CBX8, CDKN1A, EGFR, FDXR, KLK3, NPEPPS, PCSK1, PLAG1, PROS1, PSAT1, SLC25A5, TP53, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.